Patent · US Active

MK2 inhibitors and uses thereof

US9458175B2 · kind B2 · utility

15Cited by
9References
32Claims
0Family size

Assignee

Inventors

Key dates

Filing dateSep 16, 2015
Grant dateOct 4, 2016
Priority date
Expiry dateSep 16, 2035

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61P37/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention provides compounds, compositions thereof, and methods of using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.